Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Ritchie

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
International Archives of Allergy and Immunology|January 1, 1993
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blockerD M Ritchie, T Kirchner, J B Moore, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profileD C Argentieri, D M Ritchie, M P Ferro, et al.
Drug Design and Discovery|May 1, 1997
Design and discovery of RWJ 22108--a novel bronchoselective calcium channel blockerJ H Dodd, C F Schwender, J B Moore, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2Z Sui, J Guan, M P Ferro, et al.
Drug Design and Discovery|January 1, 1993
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blockerJ H Dodd, C F Schwender, R A Conley, et al.
British Journal of Cancer|July 31, 2008
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluationA M Wardley, L Hiller, H C Howard, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammationT Kirchner, D C Argentieri, A G Barbone, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenaseP J Connolly, S K Wetter, K N Beers, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Archives of Allergy and Immunology|January 1, 1993
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blockerD M Ritchie, T Kirchner, J B Moore, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profileD C Argentieri, D M Ritchie, M P Ferro, et al.
Drug Design and Discovery|May 1, 1997
Design and discovery of RWJ 22108--a novel bronchoselective calcium channel blockerJ H Dodd, C F Schwender, J B Moore, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2Z Sui, J Guan, M P Ferro, et al.
Drug Design and Discovery|January 1, 1993
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blockerJ H Dodd, C F Schwender, R A Conley, et al.
British Journal of Cancer|July 31, 2008
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluationA M Wardley, L Hiller, H C Howard, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammationT Kirchner, D C Argentieri, A G Barbone, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenaseP J Connolly, S K Wetter, K N Beers, et al.
Pageof 3